Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desloratadine for bone pain induced by G-CSF derivatives
IRCT20200220046560N2Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of desloratadine in cancer and ostealgia, sponsored by Urmia University of Medical Sciences. Started Dec 2021; status: completed.
02
Drugs
desloratadine
03
Conditions
cancerostealgia
Beyond the preview
Go deeper on IRCT20200220046560N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200220046560N2.